4186:TSETokyo Ohka Kogyo Co., Ltd. Analysis
Data as of 2026-03-14 - not real-time
₩1,293.00
Latest Price
8/10Risk
Risk Level: High
Executive Summary
E8 is trading just below its short‑term moving average, with the 20‑day SMA barely topping the current price and the 50‑day SMA remaining higher, suggesting limited upside in the near term. The RSI hovers around the midpoint, indicating neither extreme oversold nor overbought conditions, while the MACD histogram has turned positive, offering a modest bullish signal that is still below the zero line.
Fundamentally, the company is in distress: it reports negative operating margins, zero earnings per share, and a substantial debt load that exceeds its equity, resulting in a negative return on equity. Cash flow is strongly negative, and the price‑to‑sales multiple is high for a loss‑making software firm, implying the market may be overvaluing the stock relative to its financial reality. The sector is characterized by high growth expectations but also high volatility, and the broader market sentiment is in a “greed” phase, which could temporarily support price but masks underlying weakness. Investors should weigh the modest technical bullish hints against the severe fundamental deficiencies and elevated volatility before deciding on exposure.
Fundamentally, the company is in distress: it reports negative operating margins, zero earnings per share, and a substantial debt load that exceeds its equity, resulting in a negative return on equity. Cash flow is strongly negative, and the price‑to‑sales multiple is high for a loss‑making software firm, implying the market may be overvaluing the stock relative to its financial reality. The sector is characterized by high growth expectations but also high volatility, and the broader market sentiment is in a “greed” phase, which could temporarily support price but masks underlying weakness. Investors should weigh the modest technical bullish hints against the severe fundamental deficiencies and elevated volatility before deciding on exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price is near the 20‑day SMA with a bearish longer‑term trend
- MACD shows a small bullish flare but remains below zero
- Volume is decreasing, indicating weakening market participation
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Continued negative earnings and cash flow pressure
- High debt burden relative to equity
- Elevated volatility and sector‑specific risk
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Fundamental insolvency risk with no earnings outlook
- Unsustainable leverage and negative free cash flow
- Lack of dividend and limited path to profitability
Key Metrics & Analysis
Financial Health
Revenue Growth-37.70%
ROE-110.67%
ROA-28.02%
Debt/Equity102.94
Op. Cash Flow₩-10533581824
Free Cash Flow₩-10364100608
Industry P/E33.7
Technical Analysis
TrendBearish
RSI49.9
Support₩1,061.00
Resistance₩1,549.00
MA 20₩1,285.80
MA 50₩1,332.82
MA 200₩2,778.19
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta0.64
Volatility79.35%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.